Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000289047 | SCV000344942 | uncertain significance | not provided | 2016-08-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000696363 | SCV000824921 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-12-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000289047 | SCV001793259 | likely benign | not provided | 2020-09-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002418136 | SCV002677058 | likely benign | Cardiovascular phenotype | 2020-08-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |